Compumedics Share Price and Company Fundamentals



Price
$0.405
Change
-0.005 (-1.220%)
52 week
0.36 - 0.58

Last traded: Today at 3:55 AM

Compumedics Limited researches, develops, manufactures, sells, and distributes medical devices in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Grael 4K PSG:EEG amplifiers; Somté PSG; Siesta 802, an ambulatory recording device; Grael PSG; and Somté, an investigative tool. The company also provides neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Xegis Forte EMG/EP; and Xegis G:NEO 2 Channel EMG/EP systems. In addition, it offers software products, such as Profusion Sleep software suite; Profusion EEG Software; ProFusion neXus 360, a Web-based patient data and lab management system that provides integrated hardware and software solutions for sleep and neurology clinics; Multi-Modal Neuroimaging Suite; Profusion neXus Laboratory Management System to optimize administrative and operational workflow needs of diagnostic and research laboratories; Profusion neXus Scheduler for planning for staff and time; and Digital Video, a plug-in software module to add synchronized digital video capabilities to sleep and EEG systems, as well as ECG Free, Profusion Plus, Siesta extended battery pack, and summit IP products. Further, the company provides magnetoencephalography systems; brain research technologies; pharmaceutical clinical trials and research services; accessories; and a range of consumables and supplies for diagnostic and research solutions. The company was founded in 1987 and is headquartered in Abbotsford, Australia. Compumedics Limited is a subsidiary of D & DJ Burton Holdings Pty Ltd.

Key Metrics

PE ratio

-

PB ratio

3.19

Dividend yield

Beta

0.98

Market cap

$71.75M

Enterprise value

$71.18M

Company profile

Primary activitiesDevelopment and commercialisation of technology in computer based patient monitoring and diagnostic systems.
Industry / SectorMedical Devices / Healthcare
Websitehttp://www.compumedics.com.au
Mailing address30-40 Flockhart Street Abbotsford VIC 3067 Australia
Phone / Fax61 3 8420 7300 / 61 3 8420 7399
Share registryAUTOMIC REGISTRY SERVICES

Dividends

Compumedics does not pay dividends.

Company Executives

As of May 2021, following are the company executives and directors listed on Compumedics.

NameTitleAgeTotal Pay
Dr. David BurtonFounder, Exec. Chairman, CEO & Member of Medical Advisory Board61249.97k
Mr. David Francis LawsonCFO, Company Sec. & Exec. Director55281.18k
Mr. Warwick FreemanChief Technology Officer281.24k
Mr. Christoph WitteGen. Managing of Director DWL Compumedics Germany GmbH351.59k
Dr. Kerry Trent HubickLegal Counsel and Trademark, Patent & Gen. Legal Attorney
Dr. Curtis PontonChief Scientist of Neuroscan & VP
Mr. Paul SpoonerBus. Director of EMEA

Profitability and management effectiveness

Profit margin

-13.45%

Operating margin

2.70%

Return on assets

1.51%

Return on equity

-18.73%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Compumedics is 71.75M and its enterprise value is 71.18M. The enterprise value to revenue ratio of CMP is 2.05.

The CMP's stocks Beta value is 0.98 making it 2% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Compumedics (CMP)

Compumedics (ASX:CMP) Frequently Asked Questions

1. What is Compumedics's Stock Symbol?

Compumedics trades on ASX under the ticker symbol "CMP".

2. What is Compumedics's stock price today?

One share of CMP stock can currently be purchased for approximately $0.405.

3. How can I contact Compumedics?

Compumedics's mailing address is 30-40 Flockhart Street Abbotsford VIC 3067 Australia. The company can be reached via phone at 61 3 8420 7300.

4. What is Compumedics's official website?

The official website of Compumedics is http://www.compumedics.com.au.

5. Which share registry manages Compumedics's stock?

Compumedics's stock is managed by AUTOMIC REGISTRY SERVICES.